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Available online 4 April 2016Introduction. Overweight and obesity are among the most important modiﬁable risk factors for chronic
diseases and premature death. The aim of this review was to systematically assess and analyze the effects of
yoga on weight-related outcomes.
Methods.Medline/PubMed, Scopus, and the Cochrane Library were screened through March 2015 for ran-
domized controlled trials on yoga forweight-related outcomes in the general population or overweight/obese in-
dividuals. Risk of bias was assessed using the Cochrane risk of bias tool on the following domains: selection bias,
performance bias, detection bias, attrition bias, reporting bias, and other bias.
Results. Out of 445 records identiﬁed during literature search, 30 trials with a total of 2173 participants were
included. No effects onweight, bodymass index, body fat percentage orwaist circumferencewere found. In stud-
ies with healthy adult participants an effect of yoga compared to usual care was found regarding waist/hip ratio
(SMD =‐− 1.00; 95% CI =‐− 1.44,− 0.55; p b 0.001). In studies with overweight/obese participants only,
effects relative to usual care were found for body mass index (SMD =−0.99; 95% CI = −1.67,−0.31; p =
0.004). Effects however were not robust against selection bias; and publication bias could not be ruled out. No
intervention-related adverse events were reported.
Conclusions. Despite methodological drawbacks, yoga can be preliminarily considered a safe and effective
intervention to reduce body mass index in overweight or obese individuals.
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91. Introduction
Overweight and obesity are among the most important modiﬁable
risk factors for chronic diseases and premature death (World Health
Organization, 2014). About 69% of the US population are overweight
or obese (National Center for Health Statistics, 2015). Worldwide the
point prevalence is 39%; with increasing rates especially in low-
and middle-income countries (World Health Organization, 2014).
Besides inadequate diet, the most important contributing factor to
overweight and obesity is a sedentary lifestyle (Cecchini et al.,
2010). Thus, regular physical activity is recommended in medical
guidelines as the most important treatment option in non-morbid
overweight or obesity; as well as a preventive intervention
(American College of Cardiology/American Heart Association Task
Force on Practice Guidelines — Obesity Expert Panel 2013, 2014;
National Health and Medical Research Council, 2013). Given that a
considerable number of individuals with weight problems are not
adherent to recommended exercise regimens (Castellani et al.,
2003), the investigation of alternative forms of exercise for weight-
related outcomes seems warranted.
One such alternative form of physical activity that is increasingly
used for health purposes is yoga (Feuerstein, 1998; Iyengar, 1966).
Yoga is most often associated with physical postures (‘Asana’),
breath control (‘Pranayama’), and meditation (‘Dhyana’) in North
America and Europe (Feuerstein, 1998; De Michelis, 2005); and is
gaining increased popularity as a therapeutic method for various
health issues. About 14 million adult Americans (6.1% of the popula-
tion) reported that yoga had been recommended to them by a physi-
cian or therapist (Macy, 2008). Indeed, about 80% of American yoga
practitioners (more than 16 million people) reported that they had
started practice explicitly to improve their health (Birdee et al.,
2008; Clarke et al., 2002; Cramer et al., 2015a); and weight control
is among the most frequently stated reasons for starting to practice
(Park et al., 2014). While there is evidence to suggest that yoga is ef-
fective in promoting weight loss and improving body composition
(Rioux and Ritenbaugh, 2013), no systematic review and/or meta-
analysis on yoga for weight-related outcomes is available to date.
Thus, the aim of this review was to systematically assess and analyze
the effects of yoga on weight-related outcomes in the general popu-
lation and in overweight/obese individuals by means of a meta-
analysis.2. Methods
This review was conducted in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines (Moher et al., 2009) and recommendations of the Cochrane
Collaboration (Higgins and Green, 2008).
2.1. Eligibility criteria
2.1.1. Types of studies
Randomized controlled trials (RCTs) and cluster-randomized trials
were eligible. No language restrictions were applied.
2.1.2. Types of participants
Studies on
a) children or adolescents or
b) adultswere included if participants were
i) healthy or from the general population (i.e. not selected based on
their health status or weight) or
ii) overweight or obese.
The different subgroups were compared in subgroup analyses
(a vs. b; i vs. ii).
Studies were excluded if overweight or obesity were comorbidities
of diseases investigated in the trials, for example in studies investigating
obese patients with hypertension. However, studies on participants
with disease risk factor constellations, which are not a disease in itself,
such as metabolic syndrome, were eligible. Studies on pregnant
women and patients with eating disorders (anorexia nervosa, bulimia,
binge eating) were excluded.
2.1.3. Types of interventions
2.1.3.1. Experimental. Studieswere eligible if they included at least one of
the following yoga practices based on yoga theory:
i) yoga postures or sequences of yoga postures
ii) breath control, meditation, and/or
iii) lifestyle advice.
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intervention, the length, frequency or duration of the programs.
Studies on multimodal interventions including yoga among others
were excluded. Studies allowing individual co-interventions were
eligible.
2.1.3.2. Control. Studies comparing yoga to
i) usual care
ii) exercise
iii) or other active control interventions
were eligible, but studies with head to head comparisons of different
yoga interventions without non-yoga control groups were excluded.
2.1.4. Types of outcome measures
To be eligible for inclusion, studies had to assess at least one primary
weight-related outcome:
i) body weight
ii) body mass index
iii) body fat percentage
iv) waist circumference
v) waist-hip ratio.
Secondary outcomes included safety of the intervention, assessed as
number of patients with adverse events (AEs).
2.2. Search methods
The search strategy comprised three electronic databases from
their inception through March 09, 2015: Medline/PubMed, Scopus,
and the Cochrane Central Register of Controlled Trials. The litera-
ture search was constructed around search terms for 1 “yoga”
and 2 “weight” and adapted for each database as necessary. The
complete search strategy for PubMed/Medline is shown in the
appendix.
Additionally, reference lists of identiﬁed original articles or reviews;
and the tables of contents of the International Journal of Yoga Therapy
and the Journal of Yoga & Physical Therapy were searched manually;
and trials identiﬁed as randomized controlled trials in a bibliometric
analysis were checked for outcomes (Cramer et al., 2014a). Two
reviewers independently screened and selected abstracts; potentially
eligible articles were read in full by two reviewers. Disagreements
were resolved through discussionwith a third reviewer until consensus
was reached. If necessary, additional informationwas obtained from the
authors of the primary study.
2.3. Data extraction and management
Two reviewers independently extracted data on patient characteris-
tics (e.g. age, gender, ethnicity), interventions (e.g. yoga type, frequen-
cy, and duration), control interventions (e.g. type, frequency,
duration), and outcomes (e.g. outcome measures, assessment time
points) using an a priori developed data extraction form. Discrepancies
were resolved by discussion with a third reviewer until consensus was
reached.
2.4. Assessment of risk of bias in individual studies
Two reviewers independently assessed risk of bias using the
Cochrane risk of bias tool (Higgins and Green, 2008). This tool
assesses risk of bias on seven domains: random sequence genera-
tion, allocation concealment, blinding of participants and person-
nel, blinding of outcome assessment, incomplete outcome data,
selective reporting, and other sources of bias. For each domain,
risk of bias was assessed as low; unclear; or high risk of bias.Discrepancies were discussed with a third reviewer until consen-
sus was reached.
2.5. Data analysis
2.5.1. Assessment of overall effect size
Separate meta-analyses were conducted for comparisons of yoga to
different control interventions. Meta-analyses were conducted using
Review Manager 5 software (Version 5.2, The Nordic Cochrane Centre,
Copenhagen) by random effects models if at least two studies assessing
this speciﬁc outcome were available. Standardized mean differences
(SMD) with 95% conﬁdence intervals (CI) were calculated as the
difference inmeans between groups divided by the pooled standard de-
viation using Hedges' correction for small study samples (Higgins and
Green, 2008). Where no standard deviations were available, they
were calculated from standard errors, conﬁdence intervals or t-values
(Higgins and Green, 2008), or attempts were made to obtain the
missing data from the trial authors directly.
For all outcomes a negative SMD(i.e. lower scores in the yoga group)
were deﬁned to indicate beneﬁcial effects of yoga compared to the con-
trol intervention. If necessary, values were inverted (Higgins and Green,
2008). Cohen's categories were used to evaluate the magnitude of the
overall effect size with SMD b 0.2: negligible; SMD = 0.2–0.5: small;
SMD = 0.5–0.8: medium; and SMD N 0.8: large effect sizes (Cohen,
1988).
2.5.2. Assessment of heterogeneity
Statistical heterogeneity between studies was analyzed using the I2
statistics; a measure of how much variance between studies can be
attributed to differences between studies rather than chance. The mag-
nitude of heterogeneity was categorized as (1) I2 = 0–24%: low hetero-
geneity; I2 = 25–49%: moderate; I2 = 50–74%: substantial; and I2 =
75–100%: considerable (Higgins and Green, 2008; Higgins et al.,
2003). The Chi2 test was used to assess whether differences in results
are compatible with chance alone. Due to the low power of this test in
cases where only a few studies or studies with low sample size are
included, a P-value ≤ 0.10was regarded to indicate signiﬁcant heteroge-
neity (Cohen, 1988).
2.5.3. Subgroup and sensitivity analyses
Subgroup analyses were performed for the age of participants
(children/adolescents vs. adults) and their weight status (participants:
not selected based on their weight vs. overweight/obese participants).
To test the robustness of signiﬁcant results, sensitivity analyseswere
conducted for studies with high versus low risk of selection bias
(random sequence generation and allocation concealment).
If present in the respective meta-analysis, subgroup and sensitivity
analyses were also used to explore possible reasons for statistical
heterogeneity.
2.6. Risk of bias across studies
If at least ten studies were included in a meta-analysis, publication
bias was assessed by visual inspection of funnel plots generated using
Review Manager software (Higgins and Green, 2008; Egger et al.,
1997). Roughly symmetrical funnel plots were regarded to indicate
low risk of publication bias; and asymmetrical funnel plots were
regarded to indicate high risk of publication bias.
3. Results
3.1. Literature search
The literature search retrieved 435 non-duplicate records of which
158 full-texts were assessed for eligibility, and 31 of themwere eligible
(Bera and Rajapurkar, 1993; Blumenthal et al., 1989; Chen et al., 2008;
Table 1
Excluded studies.
Excluded study (reference) Reason for exclusion
McIver (2010) Commentary
Cheung et al. (2012); Corey et al. (2014); LaCroix et al. (2012); Sharma et al. (2013); Singh et al. (2011); Hoogbruin et al. (2012); Lai et al.
(2010); Trivedi and Mishra (2014)
Conference abstract
Bock et al. (2010); Bock et al. (2014); Cheema et al. (2011); Cohen et al. (2013); Kandula et al. (2013) Trial protocol
Neumark-Sztainer et al. (2011); Flaherty (2014); Guarracino et al. (2006) No clinical trial
Ades et al. (2003); Ankad et al. (2011); Ankad Roopa et al. (2011); Armstrong and Scott Smedley (2003); Bhutkar et al. (2011); Choudhary
andMishra (2013); Hunter et al. (2013); Malhotra et al. (2005); Murthy et al. (2011); Nagarathna and Nagendra (1987); Raj et al. (2011);
Ramos-Jimenez et al. (2009); Sarvottam et al. (2013); Satyanarayana et al. (1992); Sivasankaran et al. (2006); Telles et al. (1993); Telles
et al. (2010); Thomley et al. (2011); Villien et al. (2005); Yadav et al. (2012); Yadav et al. (2014); Yang and James (2014)
Not controlled
Begum et al. (2012); Cajka et al. (2013); Čajka et al. (2012); Ce et al. (2015); Chatterjee and Mondal (2014); Chaya et al. (2006); Chaya
et al. (2008); Dhananjai et al. (2013); Goncalves et al. (2011); Halder et al. (2015); Hegde et al. (2011); Herur et al. (2011); Kim et al.
(2014); Krejci (2011); Kubo et al. (2011); Madanmohan et al. (2008); Malhotra et al. (2010); Maninder et al. (2013); Miles et al. (2013);
Santhi Sri et al. (2014); Singh et al. (2008); Sukhsohale and Phatak (2012); Tyagi et al. (2014); Narendran et al. (2005a); Narendran et al.
(2005b)
Not randomized
Stein et al. (2014); Sprod et al. (2015); Emery and Blumenthal (1990) Secondary analysis
Bernstein et al. (2014); Chu et al. (2014a); Cramer et al. (2014b); Hartley et al. (2014); Innes and Vincent (2007); Jayasinghe (2004); Liu
et al. (2014); Manchanda and Madan (2014); Patel et al. (2012)
Review
Brady (2007) Not published in a
peer-reviewed journal
Ades et al. (2005); Manchanda et al. (2000); Pal et al. (2013); Pal et al. (2011); Raghuram et al. (2014); Cadmus-Bertram et al. (2013);
Littman et al. (2012); Carei et al. (2010); McIver et al. (2009); Mitchell et al. (2007); Yurtkuran et al. (2007); Cade et al. (2010);
McCaffrey et al. (2005); Murugesan et al. (2000); Rahnama et al. (2011); Cheung et al. (2014); Ebnezar et al. (2012); Sharma et al.
(2015); Nidhi et al. (2012); Nidhi et al. (2013a); Nidhi et al. (2013b); Rakhshani et al. (2015); Innes and Selfe (2012); Ikai et al. (2013);
Amita et al. (2009); Gordon et al. (2008); Nishanth et al. (2011); Shantakumari et al. (2013); Skoro-Kondza et al. (2009); Visweswaraiah
and Telles (2004)
Involved diseased participants
Dandekar (2013); Göring et al. (2013); Jorrakate et al. (2015); Rajajeyakumar et al. (2014); Santaella et al. (2011); Schmidt et al. (1997);
Sharma et al. (2014); Blumenthal et al. (1991); Elavsky and McAuley (2007b); Elavsky and McAuley (2007c)
No weight-related outcome
Arciero et al. (2014); Boxer et al. (2010); Bryan and Zipp (2014); DeBar et al. (2012); Kenny et al. (2010); Kim et al. (2008); Park et al.
(2010); Ramen et al. (2013); Sabet Sarvestani et al. (2009); Ziv et al. (2013)
No yoga
216 R. Lauche et al. / Preventive Medicine 87 (2016) 213–232Chen et al., 2010; Cohen et al., 2008a; DiPietro et al., 1998; Elavsky and
McAuley, 2007a; Harbans et al., 2011; Hegde et al., 2013; Kanaya et al.,
2014; Kanojia et al., 2013; Lee et al., 2012; Lu andWang, 2007;Mahajan
et al., 1999; Manjunath and Telles, 2012; McDermott et al., 2014;
Mooventhan and Khode, 2014; Ray et al., 2001; Sakuma et al., 2012;
Seo et al., 2012; Shukla and Gehlot, 2014; Stachenfeld et al., 1998;
Telles et al., 2014; Telles et al., 2013; Thiyagarajan et al., 2015; Tracy
and Hart, 2013; Van Puymbroeck et al., 2007; Yang et al., 2011; Khatri
et al., 2007; Kim et al., 2013; Manchanda et al., 2013), while 127 of
those full-texts were excluded (Table 1) (McIver, 2010; Cheung et al.,
2012; Corey et al., 2014; LaCroix et al., 2012; Sharma et al., 2013;
Singh et al., 2011; Hoogbruin et al., 2012; Lai et al., 2010; Trivedi and
Mishra, 2014; Bock et al., 2010; Bock et al., 2014; Cheema et al., 2011;
Cohen et al., 2013; Kandula et al., 2013; Neumark-Sztainer et al., 2011;
Flaherty, 2014; Guarracino et al., 2006; Ades et al., 2003; Ankad et al.,
2011; Ankad Roopa et al., 2011; Armstrong and Scott Smedley, 2003;
Bhutkar et al., 2011; Choudhary and Mishra, 2013; Hunter et al., 2013;
Malhotra et al., 2005; Murthy et al., 2011; Nagarathna and Nagendra,
1987; Raj et al., 2011; Ramos-Jimenez et al., 2009; Sarvottam et al.,
2013; Satyanarayana et al., 1992; Sivasankaran et al., 2006; Telles
et al., 1993; Telles et al., 2010; Thomley et al., 2011; Villien et al.,
2005; Yadav et al., 2012; Yadav et al., 2014; Yang and James, 2014;
Begum et al., 2012; Cajka et al., 2013; Čajka et al., 2012; Ce et al.,
2015; Chatterjee and Mondal, 2014; Chaya et al., 2006; Chaya et al.,
2008; Dhananjai et al., 2013; Goncalves et al., 2011; Halder et al.,
2015; Hegde et al., 2011; Herur et al., 2011; Kim et al., 2014; Krejci,
2011; Kubo et al., 2011; Madanmohan et al., 2008; Malhotra et al.,
2010; Maninder et al., 2013; Miles et al., 2013; Santhi Sri et al., 2014;
Singh et al., 2008; Sukhsohale and Phatak, 2012; Tyagi et al., 2014;
Narendran et al., 2005a; Narendran et al., 2005b; Stein et al., 2014;
Sprod et al., 2015; Emery and Blumenthal, 1990; Bar et al., 2014; Chu
et al., 2014a; Cramer et al., 2014b; Hartley et al., 2014; Innes and
Vincent, 2007; Jayasinghe, 2004; Liu et al., 2014; Manchanda and
Madan, 2014; Patel et al., 2012; Brady, 2007; Ades et al., 2005;
Manchanda et al., 2000; Pal et al., 2013; Pal et al., 2011; Raghuramet al., 2014; Cadmus-Bertram et al., 2013; Littman et al., 2012; Carei
et al., 2010; McIver et al., 2009; Mitchell et al., 2007; Yurtkuran et al.,
2007; Cade et al., 2010; McCaffrey et al., 2005; Murugesan et al., 2000;
Rahnama et al., 2011; Cheung et al., 2014; Ebnezar et al., 2012; Sharma
et al., 2015; Nidhi et al., 2012; Nidhi et al., 2013a; Nidhi et al., 2013b;
Rakhshani et al., 2015; Innes and Selfe, 2012; Ikai et al., 2013; Amita
et al., 2009; Gordon et al., 2008; Nishanth et al., 2011; Shantakumari
et al., 2013; Skoro-Kondza et al., 2009; Visweswaraiah and Telles,
2004; Dandekar, 2013; Göring et al., 2013; Jorrakate et al., 2015;
Rajajeyakumar et al., 2014; Santaella et al., 2011; Schmidt et al., 1997;
Sharma et al., 2014; Blumenthal et al., 1991; Elavsky and McAuley,
2007b; Elavsky and McAuley, 2007c; Arciero et al., 2014; Boxer et al.,
2010; Bryan and Zipp, 2014; DeBar et al., 2012; Kenny et al., 2010;
Kim et al., 2008; Park et al., 2010; Ramen et al., 2013; Sabet Sarvestani
et al., 2009; Ziv et al., 2013).
Thirty-one full-text articles reporting on 30 RCTs involving a total of
2173 participants were included in the qualitative analysis; and 27
articles on 26 RCTs were meta-analyzed (Fig. 1). All but one article
(published in Chinese) (Lu andWang, 2007) were published in English.
3.2. Study characteristics
Characteristics of the samples, interventions, outcome assessments,
and results are shown in Appendix Table 1.
3.2.1. Study and participant characteristics
Of the 30 studies that were included, 15 originated from India (Bera
and Rajapurkar, 1993; Harbans et al., 2011; Hegde et al., 2013; Kanojia
et al., 2013; Mahajan et al., 1999; Manjunath and Telles, 2012;
McDermott et al., 2014; Mooventhan and Khode, 2014; Ray et al.,
2001; Shukla and Gehlot, 2014; Telles et al., 2014; Telles et al., 2013;
Thiyagarajan et al., 2015; Khatri et al., 2007; Manchanda et al., 2013),
8 from the USA (Blumenthal et al., 1989; Cohen et al., 2008a; Elavsky
and McAuley, 2007a; Kanaya et al., 2014; Stachenfeld et al., 1998;
Tracy and Hart, 2013; Van Puymbroeck et al., 2007; Yang et al., 2011),
Fig. 1. Flowchart of the results of the literature search.
217R. Lauche et al. / Preventive Medicine 87 (2016) 213–2323 from Korea (Lee et al., 2012; Seo et al., 2012; Kim et al., 2013), 2 from
Taiwan (Chen et al., 2008; Chen et al., 2010), and one each from Japan
(Sakuma et al., 2012) and China (Lu and Wang, 2007). Ten of the trials
explicitly investigated overweight or obese individuals (Cohen et al.,
2008a; Harbans et al., 2011; Kanaya et al., 2014; Lee et al., 2012; Seo
et al., 2012; Shukla and Gehlot, 2014; Telles et al., 2014; Khatri et al.,
2007; Kim et al., 2013; Manchanda et al., 2013); and three trials were
conducted on children/adolescents (Bera and Rajapurkar, 1993; Seo
et al., 2012; Telles et al., 2013).
The sample size ranged from 17 to 204 with a median of 60.
Participant's mean age ranged from 10.4 to 75.4 years with a median
of 50.0 years. A median of 48.3% of participants was female.
3.2.2. Intervention characteristics
Two studies each used Silver yoga (Chen et al., 2008; Chen et al.,
2010) and Hatha Yoga (Ray et al., 2001; Kim et al., 2013), one each
used Restorative Yoga (Kanaya et al., 2014) Yogasana,(Sakuma et al.,
2012), Bikram (Tracy and Hart, 2013), Vinyasa Yoga (Yang et al.,
2011), and yogic lifestyle intervention (Mahajan et al., 1999), and 21
did not report the yoga style used (Appendix Table 1). Twenty-six stud-
ies reported using yoga postures while one used only breathing exer-
cises; and the majority of trials also utilized breathing, meditation or
relaxation exercises. The duration of yoga programs ranged from 2 to
52 weeks with a median of 12 weeks; participants practiced yoga on
1–7 days per week (median: 3.5) with session of 10–90 (median: 60)
minutes length. Intervention adherencewas reported by only nine stud-
ies (Blumenthal et al., 1989; Chen et al., 2008; Elavsky and McAuley,
2007a; Hegde et al., 2013; Kanaya et al., 2014; McDermott et al., 2014;
Manchanda et al., 2013; Cohen et al., 2008b; Yang et al., 2011); partici-
pants in those studies attended amean of 63.0%–95.8% (median: 78.2%)of the prescribed yoga sessions. Regarding control interventions, nine-
teen studies compared yoga to usual care or no speciﬁc treatment,
eight studies compared yoga to exercise, three studies compared yoga
to lifestyle modiﬁcation (Mahajan et al., 1999; McDermott et al., 2014;
Thiyagarajan et al., 2015); and one trial compared yoga combined
with diet to diet alone (Shukla and Gehlot, 2014). One trial compared
yoga to herbalmedicines (Manjunath and Telles, 2012) and could there-
fore not be included in the meta-analysis. In addition to a yoga group
and a non-yoga exercise control group, one trial included a combination
of yoga and exercise as a third study arm (Lu and Wang, 2007). This
third group was not included in the meta-analysis. Another trial com-
pared two different yoga interventionswith each other andwith an un-
treated control group (Chen et al., 2008). Inmeta-analysis, the two yoga
interventions could be combined into one group. In most exercise stud-
ies yoga and exercise interventions were matched for program length,
frequency and duration of the sessions.3.2.3. Outcome measures
All studies assessed outcomes immediately after the endof the inter-
vention. Bodyweightwas assessed in 22 studies, bodymass index in 17,
body fat percentage in 9, waist circumference in 15 and waist hip ratio
in 6 studies. Safety was reported in ﬁve trials only.3.3. Risk of bias in individual studies
Risk of bias in individual studies is shown in Table 2. Eleven studies
had reported adequate random sequence generation, but only seven re-
ported allocation concealment; none of the trials reported blinding of
patients and personnel; but six studies reported adequate blinding of
Table 2


















Bera (1993) unclear unclear unclear unclear unclear unclear low
Blumenthal (1989) unclear unclear unclear unclear low high low
Chen (2008) low high unclear unclear low high low
Chen (2010) unclear high unclear unclear low high high
Cohen (2008) unclear high high unclear low low high
Elavsky (2007) low unclear unclear low low high low
Harbans (2011) unclear unclear unclear unclear high low high
Hegde (2013) low unclear high high low low low
Kim (2013) low low unclear low low low low
Kanaya (2014) unclear low unclear unclear low low low
Kanojia (2013) unclear unclear unclear unclear unclear low low
Khatri (2007) unclear unclear unclear unclear unclear high high
Lee (2012) unclear unclear unclear unclear low low low
Lu (2007) unclear unclear unclear unclear unclear low low
Mahajan (1999) unclear unclear unclear unclear unclear low low
Manchanda (2013) unclear unclear high high high low unclear
Manjunath (2012) low low unclear unclear low High high
McDermott (2014) low low high low low low low
Mooventhan (2014) low low unclear unclear low low low
Ray (2001) unclear unclear unclear unclear high low low
Sakuma (2012) low low unclear unclear high High high
Shukla Ravi (2014) unclear unclear unclear unclear unclear unclear high
Seo (2012) unclear unclear unclear unclear high low low
Stachenfeld (1998) unclear unclear unclear unclear unclear low high
Telles (2013) low unclear unclear low low low high
Telles (2014) low unclear unclear unclear high unclear high
Thiyagarajan (2015) low low high high high low high
Tracy (2013) unclear unclear unclear unclear high unclear high
Van Puymbroeck (2007) unclear unclear high low high low high
Yang (2011) unclear unclear unclear low low low low
218 R. Lauche et al. / Preventive Medicine 87 (2016) 213–232outcome assessement; fourteen trials had low risk of attrition bias, and
eighteen were free of suspected selective reporting.
3.4. Analysis of overall effect
3.4.1. Primary outcomes
Meta-analyses revealed no effects on weight (Fig. 2), BMI, body fat
percentage or waist circumference for yoga compared to usual care, ex-
ercise or lifestyle modiﬁcation. For waist hip ratio a signiﬁcant effect
was found for yoga compared to usual care (SMD = −1.00; 95%
CI = −1.44 to −0.55; P b 0.0001), see Table 3. One trial compared
yoga to an herbal medicine compound but did not include statistical
tests for group differences (Harbans et al., 2011).
3.4.2. Subgroup analysis (see Appendix Tables 2–5)
No effects were found for trials including children/adolescents only.
Effects were the same in trials for adults only or for participants not
selected for weight status only compared to the complete sample.
For studies on overweight or obese participants signiﬁcant
effects were found for body mass index only (SMD = −0.99; 95%
CI =−1.67 to−0.31; P = 0.004) for yoga compared to usual care.
3.4.3. Sensitivity analysis
Due to the paucity of eligible trials, no sensitivity analyses could be
conducted for studies with low risk of selection bias.
3.4.4. Safety
Only seven studies reported safety-related data, however they stat-
ed that no adverse events were reported (Cohen et al., 2008a; Sakuma
et al., 2012), no adverse events during the intervention occurred
(Telles et al., 2014; Van Puymbroeck et al., 2007), no clinically signiﬁ-
cant adverse events were reported or observed (Harbans et al., 2011),that no special concerns were found (Chen et al., 2008) or that no
participant dropped out because of side effects (Kim et al., 2013).
3.4.5. Risk of bias across studies
Funnel plots were asymmetrical for weight, body mass index,
and waist circumference; indicating high risk of publication bias
(see Appendix Fig. 1).
4. Discussion
4.1. Summary of evidence
In this systematic review of 30 randomized controlled trials, only lit-
tle evidence for effects of yoga on weight-related outcomes has been
found. Signiﬁcant changes in body mass index were identiﬁed only in
studies with overweight/obese participants practicing yoga compared
to usual care, while signiﬁcant effects for waist hip ratio were found
for yoga compared to usual care in adults who were not selected
based on theirweight only. Effects howeverwere not robust against po-
tential methodological bias and publication bias could not be ruled out.
Furthermore safety was insufﬁciently reported.
4.2. Agreements with prior systematic reviews
Only one prior review explicitly investigated the effects of yoga on
weight and related parameters. Rioux and Ritenbaugh (2013) conduct-
ed a narrative review, and included 17 trials that used yoga as an
intervention for weight loss; among them uncontrolled, controlled
and randomized controlled trials. Their risk assessment was based
on a self-developed instrument. The authors concluded that therapeutic
yoga was frequently effective in promotion weight loss or improving
body composition in included trials. They also found that increased
Fig. 2. Forest plot and effect sizes for yoga compared to usual care, exercise and lifestyle modiﬁcation for the outcome weight.
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nents, a multi-component yoga and home practice increased the
effectiveness.
In comparison our current review found only very limited evidence
of yoga's efﬁcacy for weight control in overweight/obese patients;
however effects were not robust against bias. Subgroup analysis or
meta-regression based on intensity, duration and yoga components
could not be conducted due to heterogeneity of trials with very little
overlap. The present review had also used the Cochrane risk of bias
tool and found only a few trials with low risk of selection bias in general.
Another review on the effects of yoga on cardiovascular risk factors
found effects of yoga on waist circumference and waist/hip ratio in
high-risk groups but did not include other weight-related outcomes
(Cramer et al., 2014b). Other reviews reported comparable effects
(Chu et al., 2014b; Yang, 2007).
4.3. Strengths and weaknesses
To the best of our knowledge, this is the ﬁrst systematic review and/
or meta-analysis available on yoga for weight management. Strengthsof this review include the comprehensive literature search and the in-
clusion of yoga trials on the general population as well as overweight/
obese participants. The primary limitation of this review is the paucity
of eligible studies especially for overweight/obese participants, render-
ing further subgroup analyses impossible. Another major limitation is
the insufﬁcient reporting and/or low methodological quality of the in-
cluded studies, limiting the interpretability of the results. Intervention
adherence was reported in less than one third of the included studies;
thus the inﬂuence of adherence on study outcomes could not be evalu-
ated. The inclusion of studies onmetabolic syndrome can be regarded as
a limitation because metabolic syndrome — although not deﬁned as
a disease — might nevertheless be associated with pronounced
symptoms.
4.4. How the intervention might work
While yoga is often considered a form of exercise, beginner-level
yoga sessions are not ordinarily considered sufﬁcient for improving car-
diovascular ﬁtness (Hagins et al., 2007). More intensive forms of yoga
however can contribute to higher energy expenditure (Hagins et al.,
Table 3
Results of the meta-analysis over all studies for bodymass index, body fat percentage, waist circumference and waist hip ratio. Legend: BF: body fat; BMI: bodymass index; EX: exercise;
LSM: lifestyle modiﬁcation; UC: usual care; WC: waist circumference; WHR: waist hip ratio.








N Weight SMD [95% CI]
BMI UC Chen et al. (2008) 24.24 4.96 110 24.48 4.03 66 12.6% −0.05 [−0.36, 0.25]
Cohen et al. (2008a) −0.1 0.9 12 0.8 2.7 12 9.1% −0.43 [−1.24, 0.38]
Hedge et al. (2013) 26.8 3.5 14 26.3 4.4 15 9.7% 0.12 [−0.61, 0.85]
Lee et al. (2012) 24.24 1.43 8 26.01 1.61 8 7.4% −1.10 [−2.17,−0.03]
Manchanda et al. (2013) 31.29 3.99 34 33.65 4.9 43 11.7% −0.52 [−0.97,−0.06]
Mooventhan and Khode (2014) 22.37 4.279 40 20.82 3.336 39 11.7% 0.40 [−0.05, 0.85]
Sakuma et al. (2012) 20.7 2.7 67 20.8 2.5 31 11.9% −0.04 [−0.46, 0.39]
Seo et al. (2012) 27.56 1.5 10 29.57 2.97 10 8.4% −0.82 [−1.74, 0.10]
Shukla and Gehlot (2014) −1.97 0.7 30 −0.76 0.42 30 10.4% −2.07 [−2.70,−1.43]
Van Puymbroeck et al. (2007) 32.07 12.9 6 28.83 8.31 7 7.2% 0.28 [−0.82, 1.38]
Total 331 261 100.0% −0.40 [−0.83, 0.04]
Overall effect Z = 1.79 (P = 0.07)
Heterogeneity Chi2 = 49.55, df = 9 (P b 0.00001); I2 = 82%
EX Lu and Wang (2007) 23.08 1.77 21 23.4 1.31 21 21.1% −0.20 [−0.81, 0.40]
Stachenfeld et al. (1998) 27.0 2.7 9 26.8 1.7 7 7.9% 0.08 [−0.91, 1.07]
Telles et al. (2013) 16.34 1.88 49 16.6 2.78 49 49.4% −0.11 [−0.50, 0.29]
Telles et al. (2014) 36.61 6.54 22 33.8 5.76 22 21.6% 0.45 [−0.15, 1.05]
Total 101 99 100.0% 0.01 [−0.27, 0.29]
Overall effect Z = 0.05 (P = 0.96)
Heterogeneity Chi2 = 2.88, df = 3 (P = 0.41); I2 = 0%
BF (%) UC Bera and Rajapurkar (1993) 3.71 6.3 20 10.05 8.4 20 17.7% −0.84 [−1.49,−0.19]
Chen et al. (2010) 28.7 9.27 31 29.0 9.03 24 18.7% −0.03 [−0.57, 0.50]
Lee et al. (2012) 33.83 4.31 8 37.45 2.7 8 14.1% −0.95 [−2.00, 0.10]
Seo et al. (2012) 35.66 6.05 10 36.15 6.55 10 15.7% −0.07 [−0.95, 0.80]
Shukla and Gehlot (2014) −3.00 1.06 30 −1.03 1.37 30 18.3% −1.59 [−2.18,−1.00]
Tracy and Hart (2013) 27.3 6.3 10 21.0 8.4 11 15.5% 0.81 [−0.09, 1.71]
Total 109 103 100.0% −0.47 [−1.15, 0.22]
Overall effect Z = 1.33 (P = 0.18)
Heterogeneity Chi2 = 26.97, df = 5 (P b 0.0001); I2 = 81%
EX Lu and Wang (2007) 29.0 3.05 21 29.03 2.49 21 61.1% −0.01 [−0.62, 0.59]
Ray et al. (2001) 9.5 2.0 17 9.5 2.7 11 38.9% 0.00 [−0.76, 0.76]
Total 38 32 100.0% −0.01 [−0.48, 0.47]
Overall effect Z = 0.03 (P = 0.98)
Heterogeneity Chi2 = 0.00, df = 1 (P = 0.98); I2 = 0%
WC UC Bera and Rajapurkar (1993) 60.29 5.23 20 63.2 7.83 20 14.9% −0.43 [−1.06, 0.20]
Cohen et al. (2008a) −2.7 3.0 12 −2.7 5.0 12 13.5% 0.00 [−0.80, 0.80]
Hegde et al., 2013 89.4 9.1 14 90.0 13.7 15 14.1% −0.05 [−0.78, 0.68]
Kim et al. (2013) 90.0 5.2 17 90.52 9.1 20 14.8% −0.07 [−0.71, 0.58]
Lee et al. (2012) 85.13 1.36 8 86.44 1.95 8 11.7% −0.74 [−1.76, 0.29]
Manchanda et al. (2013) 95.12 5.12 34 98.0 7.3 43 16.2% −0.44 [−0.90, 0.01]
Shukla and Gehlot (2014) −3.53 1.5 30 −0.96 0.49 30 14.7% −2.27 [−2.93,−1.61]
Total 135 148 100.0% −0.57 [−1.17, 0.02]
Overall effect Z = 1.90 (P = 0.06)
Heterogeneity Chi2 = 32.54, df = 6 (P b 0.0001); I2 = 82%
EX Kanaya et al. (2014) −1.7 4.25 88 −0.8 5.04 83 43.1% −0.19 [−0.49, 0.11]
Lu and Wang (2007) 82.05 0.09 21 81.02 3.72 21 22.8% 0.38 [−0.23, 1.00]
Stachenfeld et al. (1998) 90.7 4.5 9 94.7 4.6 7 10.4% −0.83 [−1.87, 0.21]
Telles et al. (2014) 109.83 13.28 22 108.18 14.41 22 23.7% 0.12 [−0.47, 0.71]
Total 140 133 100.0% −0.05 [−0.42, 0.32]
Overall effect Z = 0.29 (P = 0.77)
Heterogeneity Chi2 = 5.18, df = 3 (P = 0.16); I2 = 42%
LSM McDermott et al. (2014) −4.2 4.71 20 0.7 4.71 18 42.4% −1.02 [−1.70,−0.34]
Thiyagarajan et al. (2015) 82.96 6.26 51 85.06 8.0 49 57.6% −0.29 [−0.69, 0.10]
Total 71 67 100.0% −0.60 [−1.30, 0.11]
Overall effect Z = 1.67 (P = 0.10)
Heterogeneity Chi2 = 3.28, df = 1 (P = 0.07); I2 = 70%
WHR UC Hegde et al. (2013) 0.88 0.04 15 0.93 0.08 14 34.1% −0.78 [−1.54,−0.02]
Shukla and Gehlot (2014) −0.02 0.01 30 −0.01 0.01 30 65.9% −1.11 [−1.66,−0.57]
Total 45 44 100.0% −1.00 [−1.44,−0.55]
Overall effect Z = 4.41 (P b 0.0001)
Heterogeneity Chi2 = 0.49, df = 1 (P = 0.48); I2 = 0%
EX Lu and Wang (2007) 0.69 0.03 21 0.79 0.02 21 32.6% −3.85 [−4.90,−2.79]
Stachenfeld et al. (1998) 0.92 0.03 9 0.93 0.04 7 32.9% −0.27 [−1.27, 0.72]
Telles et al. (2014) 0.91 0.05 22 0.93 0.08 22 34.5% −0.29 [−0.89, 0.30]
Total 52 50 100.0% −1.45 [−3.56, 0.66]
Overall effect Z = 1.34 (P = 0.18)
Heterogeneity Chi2 = 35.44, df = 2 (P b 0.00001); I2 = 94%
220 R. Lauche et al. / Preventive Medicine 87 (2016) 213–2322007; Mody, 2011; Ray et al., 2011); and can thus contribute to weight
loss and maintenance (Kristal et al., 2005). Moreover, yoga can amelio-
rate back and joint pain (Cramer et al., 2013a; Cramer et al., 2013b;Haaz and Bartlett, 2011; Bussing et al., 2012), and increase levels of
other, non-yoga physical activity (Bryan et al., 2012). Beyond exercise,
yoga can also encompass yogic dietary advice; as well as relaxation,
221R. Lauche et al. / Preventive Medicine 87 (2016) 213–232meditation, breath control and positive thinking. Thus, yoga has been
shown to effectively decrease chronic depression (Cramer et al.,
2013c) and stress (Chong et al., 2011); which might in turn reduce
emotional overeating and resulting overweight (Dallman et al., 2003).
This way, yoga interventions target both, physical and emotional
maintaining factors of obesity.4.5. Implications for further research
Given that the main drawback of this review was the insufﬁcient
reporting of trial methodology, authors of future research should im-
prove the reporting of yoga trials and follow commonly accepted
reporting guidelines (e.g. CONSORT) (Schulz et al., 2010). Further trials
should ensure rigorous methodology such as a-priori sample size
calculations to prevent the trial from being underpowered. They should
further ensure adequate randomization, allocation concealment,
intention-to-treat analysis, and blinding of at least outcome assessors
(Schulz et al., 2010).
Only seven trials in this review explicitly investigated overweight/
obese samples, and two of them could not be included in the meta-
analysis due to their unique control groups. The remaining trials —
when combined— only included 60 patients in the meta-analytic com-
parison of yoga and usual care. More trials on yoga for overweight or
obese people therefore are warranted. Since overweight and obesity
might also be associated with eating disorders, trials on for example
binge eating are urgently needed, as such participants may require
special consideration.
Future trials must also improve reporting of safety. Even though a
systematic review of randomized controlled trials found no evidence
for serious yoga-associated adverse events or an accumulation of
adverse events compared to usual care or exercise (Cramer et al.,
2015b), evidencewas limited because only one third of the trials actual-
ly reported safety and most of them insufﬁciently. Yoga has also beenAppendix Table 1














India No Sample size: n = 40 (n = 20
each)






45 minoccasionally associated with serious adverse events (Cramer et al.,
2013d). Especially overweight and obese patients may be required to
present a certain physical ﬁtness; and certain poses might be associated
with an increased risk of injuries. This should be an additional focus of
further trials.
4.6. Implications for clinical practice
Based on the results of this meta-analysis, no recommendation can
be made for or against yoga to inﬂuence weight-related outcomes in
children and adolescents. Despite the methodological drawbacks of
the included trials, yoga can however be preliminarily considered a
safe and effective intervention to reduce bodymass index in overweight
or obese but otherwise healthy adults. It has been shown that while
women and younger individuals are less adherent to physical activity
interventions targeting overweight and obesity (Bautista-Castano
et al., 2004), those individuals are however more likely to practice
yoga (Birdee et al., 2008; Cramer et al., 2013e). Thus, yoga can be specif-
ically considered as an alternative to other forms of physical activity for
overweight/obese individuals who are not adherent to recommended
physical activity regimens.
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(Yoga[MeSH Terms] OR Yoga*[Title/Abstract] OR Yogic[Title/Abstract] OR Asana*[Title/Abstract] OR Pranayama[Title/Abstract]) AND (Body Weights
and Measures[MeSH Terms] OR Body Weight[MeSH Terms] OR Body Composition[MeSH Terms] OR Weight*[Title/Abstract] OR Body Mass Index[Title/
Abstract] OR BMI[Title/Abstract] OR Body Fat[Title/Abstract]OR fatmass[Title/Abstract]OR Body Composition[Title/Abstract]OR Adiposity[Title/Abstract]
OR Obes*[Title/Abstract] OR Overweight[Title/Abstract] OR Waist Circumference[Title/Abstract] OR Waist-Hip Ratio*[Title/Abstract]) AND (Randomized
Controlled Trial [Publication Type] OR controlled clinical trial[Publication Type] OR randomized[Title/Abstract] OR placebo[Title/Abstract] OR
randomly[Title/Abstract] OR trial[Title/Abstract] OR groups[Title/Abstract]) NOT (Animals[MeSH Terms] NOT humans[MeSH Terms]).: male.
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USA No Sample size: n = 101 (Yoga n =
34; exercise n = 33, no treatment
n = 34)
Mean age: Yoga 67.8 ± 5.9 years;
exercise 66.5 ± 4.3 years; no




















Chen et al. (2008) Taiwan No Sample size: n = 204 (Yoga n =
64, short yoga n = 59, no
treatment n = 66)



























Chen et al. (2010) Taiwan No Sample size: n = 69 (Yoga n= 38,
control n = 31)



















Cohen et al., 2008a USA Yes Sample size: n = 26 (Yoga n =
14; control n = 12)
Mean age: Yoga 52 ± 9 years;




























USA No Sample size: n= 164 (Yoga n= 62;
exercise n = 63; usual care n = 39)
Mean age: Yoga 50.0 ± 3.7 years;
exercise 50.5 ± 3.4; usual care
48.6 ± 3.5
Gender: 100%f























India Yes Sample size: n = 63 (Yoga n =
34; control n = 29)
















6. Waist hip ratio
7. Signiﬁcant
adverse events
Hegde et al. (2013) India No Sample size: n = 29 (Yoga n= 14,
control n = 15)
Mean age: Yoga 46.5 ± 13.0 years;

















6. Waist hip ratio
7. NA
Kanaya et al. (2014) USA Yes Sample size: n = 180 (Yoga n = Restorative Yoga Stretching 12 months 1. Weight
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91, control n = 89)
Mean age: Yoga 55 ± 7 years;



























India No Sample size: n = 50 (n = 25
each)
Mean age: Yoga 18.6 ± 1.1 years;


















Khatri et al., 2007 India No Sample size: n = 101 (Yoga n =
55; control n = 46)
Mean age: Yoga 54.1 ± 8.8 years;














Kim et al. (2013) South
Korea
Yes Sample size: n = 41 (Yoga n =
20; control n = 21)
Mean age: Yoga 48.2 ± 7.2 years;

















7. Drop outs due
to side effects
Lee et al. (2012) Korea Yes Sample size: n = 16 (Yoga n = 8,
control n = 8)
Mean age: Yoga 54.8 ± 2.8 years;































2) Aerobic + yoga (group not
included in meta-analysis)











India No Sample size: n = 53 (n = 30 Yoga,
n = 23 control)
















Diet control and moderate
exercise









India Yes Sample size: n = 100 (n = 50
each)
Mean age: Yoga 62.4 ± 12.5 years;
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India No Sample size: n = 69 (n = 23
each)
Mean age: Yoga 70.1 ± 8.3 years;
control 1) 72.1 ± 9.0 years;

























India No Sample size: n = 41 (Yoga n= 21,
control n = 20)
Mean age: Yoga 47.0 ± 9.7 years,



























India No Sample size: n = 82 (n = 41
each)
Mean age: Yoga 19.8 ± 1.7 years,
















Ray et al. (2001) India No Sample size: n = 40 (n = 20 each)
Mean age: Yoga 21.9 ± 1.5 years;


























Japan No Sample size: n = 123 (Yoga n =
83, control n = 40)
Mean age: Yoga 32.6 ± 11.5 years;


















Seo et al. (2012) Korea Yes Sample size: n = 20 (n = 10
each)
Mean age: Yoga 14.7 ± 0.5 years;














































6. Waist hip ratio
7. NA
Stachenfeld et al. USA No Sample size: n = 17 (Yoga n = 8, Yoga Aerobic exercise 12 weeks 1. Weight
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control n = 9)
Mean age: Yoga 71 ± 2 years;


















Telles et al. (2013) India No Sample size: n = 98 (Yoga n= 49,
control n = 49)
Mean age: Yoga 10.4 ± 1.2 years;
























Telles et al. (2014) India Yes Sample size: n = 68 (Yoga n= 34,
control n = 34)
Age: Yoga 36.0 ± 10.3 years,
























Telles et al. (2014) India No Sample size: n = 192 (n = 96
each)
Mean age: Yoga 44.1 ± 9.4 years;



























USA No Sample size: n = 21 (Yoga n= 21,
control n = 11)
Mean age: 29.0 ± 6.1 years;



















USA No Sample size: n = 17 (Yoga n = 8,
control n = 9)
Mean age: Yoga 55.17 ± 15.0



















Yang et al. (2011) USA No Sample size: n = 25 (Yoga n= 13,
control n = 12)
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Appendix Table 2
Results of the meta-analysis for studies with overweight/obese participants only.








N Weight SMD [95% CI]
Weight UC Cohen et al. (2008a) −0.1 2.7 12 2.2 9.0 12 19.8% −0.33 [−1.14, 0.47]
Lee et al. (2012) 58.06 4.31 8 62.88 4.5 8 17.8% −1.03 [−2.10, 0.03]
Manchanda et al. (2013) 86.91 12.53 34 89.14 13.55 43 22.3% −0.17 [−0.62, 0.28]
Seo et al. (2012) 74.49 7.06 10 78.13 10.44 10 19.2% −0.39 [−1.28, 0.50]
Shukla and Gehlot (2014) −5.2 1.48 30 −2.16 1.02 30 20.9% −2.36 [−3.03,−1.69]
Total 94 103 100.0% −0.86 [−1.76, 0.05]
Overall effect Z = 1.86 (P = 0.06)
Heterogeneity Chi2 = 30.61, df = 4 (P b 0.00001); I2 = 87%
BMI UC Cohen et al., (2008a) −0.1 0.9 12 0.8 2.7 12 19.6% −0.43 [−1.24, 0.38]
Lee et al. (2012) 24.24 1.43 8 26.01 1.61 8 16.2% −1.10 [−2.17,−0.03]
Manchanda et al. (2013) 31.29 3.99 34 33.65 4.9 43 24.2% −0.52 [−0.97,−0.06]
Seo et al. (2012) 27.56 1.5 10 29.57 2.97 10 18.1% −0.82 [−1.74, 0.10]
Shukla and Gehlot (2014) −1.97 0.7 30 −0.76 0.42 30 22.0% −2.07 [−2.70,−1.43]
Total 94 103 100.0% −0.99 [−1.67,−0.31]
Overall effect Z = 2.86 (P = 0.004)
Heterogeneity Chi2 = 17.10, df = 4 (P = 0.002); I2 = 77%
BF (%) UC Lee et al. (2012) 33.83 4.31 8 37.45 2.7 8 29.1% −0.95 [−2.00, 0.10]
Seo et al. (2012) 35.66 6.05 10 36.15 6.55 10 32.5% −0.07 [−0.95, 0.80]
Shukla and Gehlot (2014) −3.00 1.055 30 −1.03 1.37 30 38.4% −1.59 [−2.18,−1.00]
Total 48 48 100.0% −0.91 [−1.86, 0.04]
Overall effect Z = 1.87 (P = 0.06)
Heterogeneity Chi2 = 8.02, df = 2 (P = 0.02); I2 = 75%
WC UC Cohen et al. (2008a) −2.7 3.0 12 −2.7 5.0 12 19.4% 0.00 [−0.80, 0.80]
Kim et al. 2013 90.0 5.2 17 90.52 9.1 20 20.7% −0.07 [−0.71, 0.58]
Lee et al. (2012) 85.13 1.36 8 86.44 1.95 8 17.4% −0.74 [−1.76, 0.29]
Manchanda et al. (2013) 95.12 5.12 34 98.0 7.3 43 22.1% −0.44 [−0.90, 0.01]
Shukla and Gehlot (2014) −3.53 1.5 30 −0.96 0.49 30 20.6% −2.27 [−2.93,−1.61]
Total 101 113 100.0% −0.71 [−1.53, 0.12]
Overall effect Z = 1.68 (P = 0.09)
Heterogeneity Chi2 = 29.77, df = 4 (P b 0.00001); I2 = 87%
EX Kanaya et al. (2014) −1.7 4.25 88 −0.8 5.04 83 79.5% −0.19 [−0.49, 0.11]
Telles et al. (2014) 109.83 13.28 22 108.18 14.41 22 20.5% 0.12 [−0.47, 0.71]
Total 110 105 100.0% −0.13 [−0.40, 0.14]
Overall effect Test for overall effect: Z = 0.95 (P = 0.34)
Heterogeneity Chi2 = 0.84, df = 1 (P = 0.36); I2 = 0%
Appendix Table 3
Results of themeta-analysis for studieswith healthy participants/general population only. Legend: BF: body fat; BMI: bodymass index; EX: exercise; LSM: lifestylemodiﬁcation; UC: usual
care; WC: waist circumference; WHR: waist hip Ratio.
Outcome Comp. Study Yoga
Mean
Yoga SD N Control
Mean
Control SD N Weight SMD [95% CI]
Weight UC Bera and Rajapurkar (1993) 44.81 9.39 20 40.28 8.65 20 11.0% 0.49 [−0.14, 1.12]
Blumenthal et al. (1989) 0.6 2.7 34 0.3 1.7 34 15.1% 0.13 [−0.34, 0.61]
Chen et al. (2008) 58.97 9.39 110 61.77 8.65 66 21.1% −0.31 [−0.61, 0.00]
Kanojia et al. (2013) 50.72 8.93 25 49.15 6.85 25 12.8% 0.19 [−0.36, 0.75]
Mooventhan and Khode (2014) 57.52 12.18 40 51.97 11.08 39 16.0% 0.47 [0.02, 0.92]
Sakuma et al. (2012) 52.1 8.0 67 52.2 7.5 31 16.7% −0.01 [−0.44, 0.41]
Yang et al. (2011) 79.24 13.52 12 85.91 13.34 10 7.3% −0.48 [−1.33, 0.38]
Total 308 225 100.0% 0.07 [−0.19, 0.34]
Overall effect Z = 0.54 (P = 0.59)
Heterogeneity Chi2 = 12.30, df = 6 (P = 0.06); I2 = 51%
EX Blumenthal et al. (1989) 0.6 2.7 34 0.5 1.7 33 34.3% 0.04 [−0.44, 0.53]
Lu and Wang (2007) 62.66 6.01 21 61.49 5.41 21 28.7% 0.20 [−0.41, 0.81]
Ray et al. (2001) 62.2 3.5 17 64.1 3.9 11 22.6% −0.50 [−1.28, 0.27]
Stachenfeld et al. (1998) 64.0 4.0 9 69.0 4.0 7 14.5% −1.18 [−2.28,−0.09]
Total 81 71 100.0% −0.21 [−0.71, 0.28]
Overall effect Z = 0.85 (P = 0.40)
Heterogeneity Chi2 = 6.08, df = 3 (P = 0.11); I2 = 51%
LSM Mahajan et al. (1999) 70.48 10.48 30 74.29 12.04 23 27.4% −0.34 [−0.88, 0.21]
McDermott et al. (2014) −0.2 1.26 20 0.6 1.26 18 19.2% −0.62 [−1.28, 0.03]
Thiyagarajan et al. (2015) 67.12 9.5 51 68.34 11.52 49 53.3% −0.11 [−0.51, 0.28]
Total 101 90 100.0% −0.27 [−0.56, 0.01]
Overall effect Z = 1.87 (P = 0.06)
Heterogeneity Chi2 = 1.78, df = 2 (P = 0.41); I2 = 0%
BMI UC Chen et al. (2008) 24.24 4.96 110 24.48 4.03 66 44.7% −0.05 [−0.36, 0.25]
Hegde et al. (2013) 26.8 3.5 14 26.3 4.4 15 9.7% 0.12 [−0.61, 0.85]
Mooventhan and Khode (2014) 22.37 4.28 40 20.82 3.34 39 15.3% 0.40 [−0.05, 0.85]
Sakuma et al. (2012) 20.7 2.7 67 20.8 2.5 31 16.8% −0.04 [−0.46, 0.39]
Van Puymbroeck et al. (2007) 32.07 12.9 6 28.83 8.31 7 2.5% 0.28 [−0.82, 1.38]
Total 237 158 100.0% 0.07 [−0.13, 0.28]
Overall effect Z = 0.69 (P = 0.49)
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Appendix Table 3 (continued)
Outcome Comp. Study Yoga
Mean
Yoga SD N Control
Mean
Control SD N Weight SMD [95% CI]
Heterogeneity Chi2 = 3.12, df = 4 (P = 0.54); I2 = 0%
EX Lu and Wang (2007) 23.08 1.77 21 23.4 1.31 21 26.9% −0.20 [−0.81, 0.40]
Stachenfeld et al. (1998) 27.0 2.7 9 26.8 1.7 7 10.1% 0.08 [−0.91, 1.07]
Telles et al. (2013) 16.34 1.88 49 16.6 2.78 49 63.0% −0.11 [−0.50, 0.29]
Total 79 77 100.0% −0.11 [−0.43, 0.20]
Overall effect Z = 0.71 (P = 0.48)
Heterogeneity Chi2 = 0.23, df = 2 (P = 0.89); I2 = 0%
BF (%) UC Bera and Rajapurkar (1993) 3.71 6.3 20 10.05 8.4 20 34.3% −0.84 [−1.49,−0.19]
Chen et al. (2010) 28.7 9.27 31 29.0 9.03 24 36.9% −0.03 [−0.57, 0.50]
Tracy and Hart (2013) 27.3 6.3 10 21.0 8.4 11 28.8% 0.81 [−0.09, 1.71]
Total 61 55 100.0% −0.07 [−0.89, 0.76]
Overall effect Z = 0.16 (P = 0.87)
Heterogeneity Chi2 = 8.86, df = 2 (P = 0.01); I2 = 77%
EX Lu and Wang (2007) 29.0 3.05 21 29.03 2.49 21 61.1% −0.01 [−0.62, 0.59]
Ray et al. (2001) 9.5 2.0 17 9.5 2.7 11 38.9% 0.00 [−0.76, 0.76]
Total 38 32 100.0% −0.01 [−0.48, 0.47]
Overall effect Z = 0.03 (P = 0.98)
Heterogeneity Chi2 = 0.00, df = 1 (P = 0.98); I2 = 0%
WC UC Bera and Rajapurkar (1993) 60.29 5.23 20 63.2 7.83 20 57.4% −0.43 [−1.06, 0.20]
Hegde et al. (2013) 89.4 9.1 14 90.0 13.7 15 42.6% −0.05 [−0.78, 0.68]
Total 34 35 100.0% −0.27 [−0.74, 0.21]
Overall effect Z = 1.10 (P = 0.27)
Heterogeneity Chi2 = 0.60, df = 1 (P = 0.44); I2 = 0%
EX Lu and Wang (2007) 82.05 0.09 21 81.02 3.72 21 56.3% 0.38 [−0.23, 1.00]
Stachenfeld et al. (1998) 90.7 4.5 9 94.7 4.6 7 43.7% −0.83 [−1.87, 0.21]
Total 30 28 100.0% −0.15 [−1.33, 1.03]
Overall effect Z = 0.25 (P = 0.81)
Heterogeneity Chi2 = 3.90, df = 1 (P = 0.05); I2 = 74%
LSM McDermott et al. (2014) −4.2 4.71 20 0.7 4.71 18 42.4% −1.02 [−1.70,−0.34]
Thiyagarajan et al. (2015) 82.96 6.26 51 85.06 8.0 49 57.6% −0.29 [−0.69, 0.10]
Total 71 67 100.0% −0.60 [−1.30, 0.11]
Overall effect Z = 1.67 (P = 0.10)
Heterogeneity Chi2 = 3.28, df = 1 (P = 0.07); I2 = 70%
WHR UC Hegde et al. (2013) 0.88 0.04 15 0.93 0.08 14 34.1% −0.78 [−1.54,−0.02]
Shukla and Gehlot (2014) −0.02 0.01 30 −0.01 0.01 30 65.9% −1.11 [−1.66,−0.57]
Total 45 44 100.0% −1.00 [−1.44,−0.55]
Overall effect Z = 4.41 (P b 0.0001)
Heterogeneity Chi2 = 0.49, df = 1 (P = 0.48); I2 = 0%
EX Lu and Wang (2007) 0.69 0.03 21 0.79 0.02 21 32.6% −3.85 [−4.90,−2.79]
Stachenfeld et al. (1998) 0.92 0.03 9 0.93 0.04 7 32.9% −0.27 [−1.27, 0.72]
Telles et al. (2014) 0.91 0.05 22 0.93 0.08 22 34.5% −0.29 [−0.89, 0.30]
Total 52 50 100.0% −1.45 [−3.56, 0.66]
Overall effect Z = 1.34 (P = 0.18)
Heterogeneity Chi2 = 35.44, df = 2 (P b 0.00001); I2 = 94%
Appendix Table 4
Results of the meta-analysis for studies with children/adolescent participants only. Legend: BF: body fat; UC: usual care.








N Weight SMD [95% CI]
Weight UC Bera and Rajapurkar (1993) 44.81 9.39 20 40.28 8.65 20 56.5% 0.49 [−0.14, 1.12]
Seo et al. (2012) 74.49 7.06 10 78.13 10.44 10 43.5% −0.39 [−1.28, 0.50]
Total 30 30 100.0% 0.11 [−0.75, 0.97]
Overall effect Z = 0.25 (P = 0.81)
Heterogeneity Chi2 = 2.53, df = 1 (P = 0.11); I2 = 60%
BF (%) UC Bera and Rajapurkar (1993) 3.71 6.3 20 10.05 8.4 20 57.8% −0.84 [−1.49,−0.19]
Seo et al. (2012) 35.66 6.05 10 36.15 6.55 10 42.2% −0.07 [−0.95, 0.80]
Total 30 30 100.0% −0.52 [−1.25, 0.22]
Overall effect Z = 1.37 (P = 0.17)
Heterogeneity Chi2 = 1.88, df = 1 (P = 0.17); I2 = 47%
Appendix Table 5
Results of themeta-analysis for studies with adult participants only. Legend: BF: body fat; BMI: body mass index; EX: exercise; LSM: lifestyle modiﬁcation; UC: usual care; WC: waist cir-
cumference; WHR: waist hip Ratio.








N Weight SMD [95% CI]
Weight UC Blumenthal et al. (1989) 0.6 2.7 34 0.3 1.7 34 10.9% 0.13 [−0.34, 0.61]
Chen et al. (2008) 58.97 9.39 110 61.77 8.65 66 11.9% −0.31 [−0.61, 0.00]
Cohen et al. (2008a) −0.1 2.7 12 2.2 9.0 12 8.6% −0.33 [−1.14, 0.47]
Kanojia et al. (2013) 50.72 8.93 25 49.15 6.85 25 10.4% 0.19 [−0.36, 0.75]
(continued on next page)
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Appendix Table 5 (continued)








N Weight SMD [95% CI]
Lee et al. (2012) 58.06 4.31 8 62.88 4.5 8 7.0% −1.03 [−2.10, 0.03]
Manchanda et al. (2013) 86.91 12.53 34 89.14 13.55 43 11.0% −0.17 [−0.62, 0.28]
Mooventhan and Khode (2014) 57.52 12.18 40 51.97 11.08 39 11.1% 0.47 [0.02, 0.92]
Sakuma et al. (2012) 52.1 8.0 67 52.2 7.5 31 11.2% −0.01 [−0.44, 0.41]
Shukla and Gehlot (2014) −5.2 1.48 30 −2.16 1.02 30 9.6% −2.36 [−3.03,−1.69]
Yang et al. (2011) 79.24 13.52 12 85.91 13.34 10 8.3% −0.48 [−1.33, 0.38]
Total 372 298 100.0% −0.34 [−0.76, 0.08]
Overall effect Z = 1.57 (P = 0.12)
Heterogeneity Chi2 = 56.67, df = 9 (P b 0.00001); I2 = 84%
EX Blumenthal et al. (1989) 0.6 2.7 34 0.5 1.7 33 24.4% 0.04 [−0.44, 0.53]
Kanaya et al. (2014) −1.3 2.83 88 −0.7 3.21 83 37.6% −0.20 [−0.50, 0.10]
Lu and Wang (2007) 62.66 6.01 21 61.49 5.41 21 18.2% 0.20 [−0.41, 0.81]
Ray et al. (2001) 62.2 3.5 17 64.1 3.9 11 12.7% −0.50 [−1.28, 0.27]
Stachenfeld et al. (1998) 64.0 4.0 9 69.0 4.0 7 7.1% −1.18 [−2.28,−0.09]
Total 169 154 100.0% −0.18 [−0.49, 0.14]
Overall effect Z = 1.11 (P = 0.27)
Heterogeneity Chi2 = 6.21, df = 4 (P = 0.18); I2 = 36%
LSM Mahajan et al. (1999) 70.48 10.48 30 74.29 12.04 23 27.4% −0.34 [−0.88, 0.21]
McDermott et al. (2014) −0.2 1.26 20 0.6 1.26 18 19.2% −0.62 [−1.28, 0.03]
Thiyagarajan et al. (2015) 67.12 9.5 51 68.34 11.52 49 53.3% −0.11 [−0.51, 0.28]
Total 101 90 100.0% −0.27 [−0.56, 0.01]
Overall effect Z = 1.87 (P = 0.06)
Heterogeneity Chi2 = 1.78, df = 2 (P = 0.41); I2 = 0%
BMI UC Chen et al. (2008) 24.24 4.96 110 24.48 4.03 66 13.7% −0.05 [−0.36, 0.25]
Cohen et al. (2008a) −0.1 0.9 12 0.8 2.7 12 9.4% −0.43 [−1.24, 0.38]
Hegde et al. (2013) 24.24 4.96 110 24.48 4.03 66 13.7% −0.05 [−0.36, 0.25]
Lee et al. (2012) 24.24 1.43 8 26.01 1.61 8 7.4% −1.10 [−2.17,−0.03]
Manchanda et al. (2013) 31.29 3.99 34 33.65 4.9 43 12.5% −0.52 [−0.97,−0.06]
Mooventhan and Khode (2014) 22.37 4.28 40 20.82 3.34 39 12.6% 0.40 [−0.05, 0.85]
Sakuma et al. (2012) 20.7 2.7 67 20.8 2.5 31 12.7% −0.04 [−0.46, 0.39]
Shukla and Gehlot (2014) −1.97 0.7 30 −0.76 0.42 30 10.9% −2.07 [−2.70,−1.43]
Van Puymbroeck et al. (2007) 32.07 12.9 6 28.83 8.31 7 7.2% 0.28 [−0.82, 1.38]
Total 417 302 100.0% −0.36 [−0.77, 0.05]
Overall effect Z = 1.71 (P = 0.09)
Heterogeneity Chi2 = 48.23, df = 8 (P b 0.00001); I2 = 83%
EX Lu and Wang (2007) 23.08 1.77 21 23.4 1.31 21 41.1% −0.20 [−0.81, 0.40]
Stachenfeld et al. (1998) 27.0 2.7 9 26.8 1.7 7 16.9% 0.08 [−0.91, 1.07]
Telles et al. (2014) 36.61 6.54 22 33.8 5.76 22 42.0% 0.45 [−0.15, 1.05]
Total 52 50 100.0% 0.12 [−0.30, 0.54]
Overall effect Z = 0.56 (P = 0.58)
Heterogeneity Chi2 = 2.24, df = 2 (P = 0.33); I2 = 11%
BF (%) UC Chen et al. (2010) 28.7 9.27 31 29.0 9.03 24 27.0% −0.03 [−0.57, 0.50]
Lee et al. (2012) 33.83 4.31 8 37.45 2.7 8 22.5% −0.95 [−2.00, 0.10]
Shukla and Gehlot (2014) −3.0 1.06 30 −1.03 1.37 30 26.6% −1.59 [−2.18,−1.00]
Tracy and Hart (2013) 27.3 6.3 10 21.0 8.4 11 23.9% 0.81 [−0.09, 1.71]
Total 79 73 100.0% −0.45 [−1.50, 0.59]
Overall effect Z = 0.85 (P = 0.40)
Heterogeneity Chi2 = 25.09, df = 3 (P b 0.0001); I2 = 88%
EX Lu and Wang (2007) 29.0 3.05 21 29.03 2.49 21 61.1% −0.01 [−0.62, 0.59]
Ray et al. (2001) 9.5 2.0 17 9.5 2.7 11 38.9% 0.00 [−0.76, 0.76]
Total 38 32 100.0% −0.01 [−0.48, 0.47]
Overall effect Z = 0.03 (P = 0.98)
Heterogeneity Chi2 = 0.00, df = 1 (P = 0.98); I2 = 0%
WC UC Cohen et al. (2008a) −2.7 3.0 12 −2.7 5.0 12 16.1% 0.00 [−0.80, 0.80]
Hegde et al. (2013) 89.4 9.1 14 90.0 13.7 15 16.6% −0.05 [−0.78, 0.68]
Kim et al. (2013) 90.0 5.2 17 90.52 9.1 20 17.3% −0.07 [−0.71, 0.58]
Lee et al. (2012) 85.13 1.36 8 86.44 1.95 8 14.2% −0.74 [−1.76, 0.29]
Manchanda et al. (2013) 95.12 5.12 34 98.0 7.3 43 18.6% −0.44 [−0.90, 0.01]
Shukla and Gehlot (2014) −3.53 1.5 30 −0.96 0.49 30 17.2% −2.27 [−2.93,−1.61]
Total 115 128 100.0% −0.60 [−1.31, 0.11]
Overall effect Z = 1.65 (P = 0.10)
Heterogeneity Chi2 = 32.30, df = 5 (P b 0.00001); I2 = 85%
EX Kanaya et al. (2014) −1.7 4.25 88 −0.8 5.04 83 43.1% −0.19 [−0.49, 0.11]
Lu and Wang (2007) 82.05 0.09 21 81.02 3.72 21 22.8% 0.38 [−0.23, 1.00]
Stachenfeld et al. (1998) 90.7 4.5 9 94.7 4.6 7 10.4% −0.83 [−1.87, 0.21]
Telles et al. (2014) 109.83 13.28 22 108.18 14.41 22 23.7% 0.12 [−0.47, 0.71]
Total 140 133 100.0% −0.05 [−0.42, 0.32]
Overall effect Z = 0.29 (P = 0.77)
Heterogeneity Chi2 = 5.18, df = 3 (P = 0.16); I2 = 42%
LSM McDermott et al. (2014) −4.2 4.71 20 0.7 4.71 18 42.4% −1.02 [−1.70,−0.34]
Thiyagarajan et al. (2015) 82.96 6.26 51 85.06 8.0 49 57.6% −0.29 [−0.69, 0.10]
Total 71 67 100.0% −0.60 [−1.30, 0.11]
Overall effect Z = 1.67 (P = 0.10)
Heterogeneity Chi2 = 3.28, df = 1 (P = 0.07); I2 = 70%
WHR UC Hegde et al. (2013) 0.88 0.04 15 0.93 0.08 14 34.1% −0.78 [−1.54,−0.02]
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N Weight SMD [95% CI]
Shukla and Gehlot (2014) −0.02 0.01 30 −0.01 0.01 30 65.9% −1.11 [−1.66,−0.57]
Total 45 44 100.0% −1.00 [−1.44,−0.55]
Overall effect Z = 4.41 (P b 0.0001)
Heterogeneity Chi2 = 0.49, df = 1 (P = 0.48); I2 = 0%
EX Lu and Wang (2007) 0.69 0.03 21 0.79 0.02 21 32.6% −3.85 [−4.90,−2.79]
Stachenfeld et al. (1998) 0.92 0.03 9 0.93 0.04 7 32.9% −0.27 [−1.27, 0.72]
Telles et al. (2014) 0.91 0.05 22 0.93 0.08 22 34.5% −0.29 [−0.89, 0.30]
Total 52 50 100.0% −1.45 [−3.56, 0.66]
Overall effect Z = 1.34 (P = 0.18)
Heterogeneity Chi2 = 35.44, df = 2 (P b 0.00001); I2 = 94%
Appendix Fig. 1. Funnel plot for yoga compared to usual care, exercise and lifestyle mod-
iﬁcation for the outcome weight.
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Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ypmed.2016.03.013.
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